The Clorox Company (NYSE:CLX) Shares Sold by Sunbelt Securities Inc.

Sunbelt Securities Inc. trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 27.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,635 shares of the company’s stock after selling 620 shares during the period. Sunbelt Securities Inc.’s holdings in Clorox were worth $266,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in the business. Prospera Private Wealth LLC purchased a new stake in Clorox during the third quarter worth approximately $27,000. Innealta Capital LLC acquired a new stake in Clorox during the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC lifted its position in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the last quarter. Continuum Advisory LLC boosted its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares in the last quarter. Finally, Family Firm Inc. purchased a new position in shares of Clorox in the 2nd quarter valued at $31,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Up 0.2 %

CLX stock opened at $164.96 on Friday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company has a fifty day moving average of $163.77 and a 200-day moving average of $151.54. The stock has a market capitalization of $20.42 billion, a PE ratio of 57.48, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.49 EPS. As a group, analysts expect that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 2.96%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of research reports. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and upped their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Barclays lifted their price target on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their price objective for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, DA Davidson lifted their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Five investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.